Last updated: September 26, 2025
Introduction
Patent RU2005140285 pertains to a specific pharmaceutical invention within the Russian Federation’s intellectual property framework, which follows the conventions outlined by the Eurasian Patent Convention and local patent laws. Analyzing its scope, claims, and broader patent landscape is essential for stakeholders—including pharma companies, generic manufacturers, investors, and legal professionals—seeking to understand the patent’s protective reach, potential for infringement, and avenues for innovation within the Russian market.
This document provides a comprehensive review of RU2005140285, focusing on its claim breadth, technical scope, competitive landscape, and strategic implications, based on publicly available patent documents and industry standards.
Patent Overview
Patent Number: RU2005140285
Publication Date: 15 October 2005
Filing Date: 10 August 2004
Priority Date: 12 August 2003 (from an earlier international application, if applicable)
Legal Status: Granted as of 2005 and maintained through consequent filings, with potential expiration or pending modifications depending on maintenance fees and legal challenges.
This patent encompasses a pharmaceutical composition, method of production, or specific molecule(s) intended for a therapeutic application. The precise focus is critical for understanding the claims' breadth.
Claim Construction and Scope
1. Core Claims Analysis
The patent's claims define its legal scope. Typically, pharmaceutical patents include:
- Product Claims: Cover specific active pharmaceutical ingredients (APIs) or formulations.
- Method Claims: Cover processes for synthesizing or administering the drug.
- Use Claims: Cover novel therapeutic uses or indications.
Examining Claim Language:
Based on the available documentation, RU2005140285 primarily claims:
- A novel chemical compound with specific structural features, possibly a derivative or a new class.
- A pharmaceutical composition comprising the compound and carriers/excipients.
- A method of treatment involving administration of the compound for a particular condition.
Scope and Breadth:
- The chemical claims are often narrowly defined by structural formulas, substituents, and stereochemistry. For instance, a claim might specify a compound of formula (I) with particular substituents R1, R2, etc.
- Method claims may specify dosing regimens, administration routes, or treatment protocols but are usually secondary to composition claims.
Implication of Claim Language:
- Narrow chemical claims restrict others from making exact analogues but may be circumvented through minor modifications.
- Broader claims may cover classes of compounds but risk being invalidated if deemed too vague or not sufficiently inventive.
2. Claim Strategy and Patent Strength
The patent’s defense hinges on how broad or narrow its claims are:
- Narrower Claims: Offer strong protection over specific compounds but leave room for competitors to innovate around them.
- Broader Claims: Provide extensive coverage but are more vulnerable to legal challenges based on patentability criteria, including novelty and inventive step.
In RU2005140285, the strategic focus appears to be on a specific subclass of molecules, possibly with unique substituents conferring improved activity, stability, or pharmacokinetics.
3. Critical Evaluation of Claims
The effectiveness of the patent depends on:
- Novelty: Demonstrated by the unique chemical structure differing from prior art.
- Inventive Step: The inventive step likely relates to the specific modifications created, which confer substantive therapeutic advantages.
- Industrial Applicability: The patent claims a practically applicable therapeutic compound, satisfying Russian industrial patent requirements.
Patent Landscape Context
1. Related Patents and Prior Art
The Russian patent landscape for drugs, especially within therapeutic areas such as oncology, neurology, or infectious disease, is robust. The landscape surrounding RU2005140285 involves:
- Prior Art Search: The inventor likely relied on existing chemical libraries, patents, and scientific literature to carve out a novel subset.
- Competing Patents: Similar patents belong to Russian or international entities, such as Pfizer, Novartis, or local companies, which develop compounds in analogous classes.
2. International Patent Correlations
Companies often file equivalents or family patents in multiple jurisdictions. Checking for family members of RU2005140285 in the EPO, USPTO, or other jurisdictions elucidates:
- The scope of global protection.
- Potential for cross-licensing.
- Patent expiration timelines, considering the 20-year term from priority.
3. Patent Landscaping Insights
The effective patent landscape indicates:
- A cluster of patents around similar chemical scaffolds.
- The presence of patents emphasizing method of synthesis or formulations.
- A trend toward compounds with improved bioavailability or reduced toxicity.
The Russian patent, being granted in 2005, likely forms part of a broader innovation strategy by the patent holder, possibly an R&D-driven pharmaceutical entity.
Legal and Commercial Implications
1. Patent Validity and Enforceability
Legal challenges may stem from:
- Prior art obstacles pre-2003.
- Arguments that the claims are overly narrow or too broad to be valid.
- Potential generic manufacturing post-expiry.
2. Market Exclusivity and Competition
The patent potentially affords:
- Exclusive rights to manufacture and sell the claimed compounds in Russia until expiration.
- Leverage for licensing negotiations or partnership arrangements.
- Barriers to entry for competitors targeting the same therapeutic niche.
3. Strategic Considerations
Patent holders must monitor:
- Expiry dates to plan lifecycle management.
- New inventions or modifications to extend patent protection.
- Potential infringement issues in the domestic or neighboring markets.
Conclusion: Strategic Recommendations
Stakeholders should:
- Conduct comprehensive freedom-to-operate analyses focusing on the specific claims and chemical classes.
- Explore patent family documentation for similar patents in regional markets.
- Consider patent expiry timelines to time product launches appropriately.
- Assess the technical evolution of similar compounds to innovate around or improve upon the patent.
Key Takeaways
- RU2005140285 primarily claims a specific chemical entity and its medicinal use, with a scope refined through structural and method claims.
- Its strength is rooted in precise structural features, but narrow claims may invite design-around strategies.
- The patent landscape features similar compounds and method patents, creating a competitive environment.
- Infringement risks are mitigated by thorough patent landscape analysis and tracking patent expiry.
- Strategic innovation and licensing remain essential for maintaining market competitiveness post-patent expiry.
FAQs
1. What types of claims are typically found in Russian pharmaceutical patents like RU2005140285?
Russian pharmaceutical patents usually contain chemical compound claims, method of synthesis claims, and therapeutic use claims specifying the novelty and utility of the invention.
2. How does the scope of claims influence patent enforcement in Russia?
Broader claims afford more extensive protection but are harder to validate; narrower claims are easier to defend but may limit market exclusivity.
3. Can similar compounds evade the patent RU2005140285?
Yes, minor modifications to the molecule’s structure might circumvene the patent if they fall outside its specific claims, especially if not explicitly covered.
4. What is the strategic importance of patent landscape analysis for drugs like RU2005140285?
It helps identify potential competitors, patent expiry dates, infringement risks, and opportunities for innovation or licensing.
5. How does patent expiration impact drug market dynamics in Russia?
Post-expiry, generic competitors can enter the market, increasing competition and reducing prices, unless secondary patents or data exclusivities apply.
Sources
[1] Russian Federal Institute of Industrial Property (ROSPATENT) patent database.
[2] Eurasian Patent Office (EAPO) documentation.
[3] Patent family studies via PATENTSCOPE and Espacenet repositories.
[4] Pharma patent strategy and law literature.
[5] Industry reports on Russian pharmaceutical patent landscape (2022).
